Skip to main content
Caplight Logo









Novasign GmbH

Novasign GmbH

Private
ViennaHealthcare & Life Scienceshttps://novasign.at/

Last Round

Seed

Sep 4, 2025

Total Funding Raised

$1.34M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Novasign GmbH is a biotechnology company that provides hybrid modeling software and consulting services to accelerate bioprocess development for the biopharmaceutical, enzyme, and cultured food industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Smart Manufacturing, ML Platforms, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

hybrid modelingdigital twinbioprocess developmentbioprocessing softwarein-silico simulationbioprocess optimizationprocess modelingDesign of ExperimentsDoE softwareupstream processingdownstream processingprocess scale-upbiopharmaceuticalMSATManufacturing, Science, and Technologycultured foodenzyme productionProcess Analytical TechnologyPAT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novasign GmbH Comparables

Compare Novasign GmbH with similar companies based on industry and business-model similarity.

Novasign GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DataHow AG
90%
AnalysisMode
85%
Algocell
84%

Novasign GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 4, 2025

Key People

Founding team and executive leadership

Mark Duerkop

Co-Founder and CEO

Founding Team

Novasign GmbH Investors

Notable investors and investment history

Novasign GmbH investors
InvestorRounds
Austria WirtschaftsserviceGrant
FFG Austrian Research Promotion AgencyGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 314% MoM, from 303 to 1.3K.

  • Jun 29, 2026

    Grew 20% QoQ, from 20 to 24 employees.

Novasign GmbH Filings

Explore SEC and related filing metadata, where available.

Novasign GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Novasign GmbH's valuation, stock price, and market status.

Is Novasign GmbH a public or private company?

Novasign GmbH is a private company.

What is the current stock price of Novasign GmbH?

Novasign GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is Novasign GmbH worth (valuation)?

Valuation information for Novasign GmbH is not publicly available.

Can I buy Novasign GmbH stock?

Novasign GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Novasign GmbH's last funding round?

Novasign GmbH's most recent funding round was Seed on September 4, 2025.

Who are the main investors in Novasign GmbH?

Key investors in Novasign GmbH include Austria Wirtschaftsservice, FFG Austrian Research Promotion Agency.

Will Novasign GmbH IPO soon?

No public IPO plans have been announced for Novasign GmbH.

How can I track Novasign GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Novasign GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVienna
Employee Range18
Year Founded2019
Last FundingSep 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?